2019
Connective Tissue Disease–Associated Interstitial Lung Disease Evaluation and Management
Antin-Ozerkis D, Hinchcliff M. Connective Tissue Disease–Associated Interstitial Lung Disease Evaluation and Management. Clinics In Chest Medicine 2019, 40: 617-636. PMID: 31376896, DOI: 10.1016/j.ccm.2019.05.008.Peer-Reviewed Original ResearchConceptsNonpharmacologic management strategiesMainstay of therapyConnective tissue diseaseInterstitial lung diseaseRate of progressionDisease activityTherapy initiationTissue diseaseRadiographic findingsLung diseaseDrug toxicityDisease severityDisease evaluationMultidisciplinary approachPatientsDiseaseImportant contributorImmunosuppressionMorbidityTherapyInfectionMainstayMortalityProgressionTrials
2010
An Update on Nonspecific Interstitial Pneumonia
Antin-Ozerkis D, Rubinowitz A. An Update on Nonspecific Interstitial Pneumonia. Clinical Pulmonary Medicine 2010, 17: 122-128. DOI: 10.1097/cpm.0b013e3181daae17.Peer-Reviewed Original ResearchNonspecific interstitial pneumoniaIdiopathic interstitial pneumoniaIdiopathic pulmonary fibrosisInterstitial pneumoniaPulmonary fibrosisIdiopathic nonspecific interstitial pneumoniaConnective tissue diseaseAmerican Thoracic SocietyParticular idiopathic pulmonary fibrosisNSIP patternImmunosuppressive therapyDrug hypersensitivityOptimal therapyTissue diseaseRadiographic findingsClinical historyFinal diagnosisRadiographic patternsThoracic SocietyClinical circumstancesOccupational exposureCorrect diagnosisPneumoniaUnderlying causeAdditional studies